Topic: NOVARTIS
98 results were found.
Novartis opens 40 mln euro plant in Slovenia - February 14, 2025
Novartis to acquire MorphoSys for 2.7 billion euros - February 7, 2024
Novartis signs gene therapy deal with Voyager for $100 mln upfront and possible $1.2 billion - January 3, 2024
Novartis shares Sandoz H1 results ahead of spin off - September 5, 2023
Novartis acquires Chinook Therapeutics for $3.2bn - August 15, 2023
Novartis acquires DTx Pharma for $1 billion - July 19, 2023
Novartis Q2 net income $2.32 billion, Sandoz to go alone - July 18, 2023
Samsung Biologics signs $390.9 million deal with Novartis - July 11, 2023
Novartis to buy Chinook for up to $3.5 billion - June 12, 2023
Novartis Q1 income $2.29 billion - April 25, 2023
Novartis Q4 income declined 91 percent - February 1, 2023
Novartis Q3 core operating income up 5% - October 25, 2022
Novartis to cut 400 jobs in Ireland - October 14, 2022
Switzerland competition authorities probe Novartis over suspected patent abuse - September 15, 2022
Novartis announces intention to separate Sandoz business to create a standalone company - August 25, 2022
Novartis to cut 1,400 jobs - August 24, 2022
Novartis says two children died after receiving gene therapy Zolgensma - August 12, 2022
Novartis lung cancer drug Tabrecta gets EU approval - June 23, 2022
Novartis targeted by hackers, no sensitive data stolen - June 6, 2022
International Process Plants buys Novartis UK's pharmaceutical manufacturing site - May 25, 2022
Greece will sue Novartis claiming compensation for illegal practices - May 16, 2022
Novartis Q1 net sales $12.5 billion - April 26, 2022
Novartis Q4 net income $16.31 billion - February 2, 2022
Novartis in-licenses COVID-19 treatment ensovibep from Molecular Partners - January 10, 2022
Novartis to buy Gyroscope Therapeutics for up to $1.5 billion - December 22, 2021
Novartis and BeiGene in $1 billion anti cancer therapy deal - December 20, 2021
Novartis to Sell Roche stake for $20.7 billion - November 4, 2021
Novartis extends deal to make Pfizer BioNTech vaccines - October 21, 2021
Greece: Two witnesses in Novartis case remain protected - September 9, 2021
Novartis Q2 net sales $13.0 billion - July 21, 2021
Novartis, Molecular Partners to start clinical trials of COVID-19 drug - May 27, 2021
Novartis to help make Pfizer-Biontech COVID-19 vaccine - January 29, 2021
Novartis Q4 profit rises - January 26, 2021
Novartis to buy Cadent for up to $770 million - December 17, 2020
Novartis Q3 net income declined - October 27, 2020
Indiana AG Hill announces $678m national settlement with Novartis over kickbacks - September 23, 2020
France fine Novartis, Roche and Genentech $500 million - September 10, 2020
Novartis Pharmaceuticals to pay $4.4 million to resolve medicaid fraud allegations - August 7, 2020
Novartis Q2 net income $1.87 billion - July 21, 2020
Novartis launches zero profit portfolio of medicines for symptomatic treatment of coronavirus - July 16, 2020
Novartis to settle allegations of improper payments to patients and physicians - July 2, 2020
SEC charges Novartis AG with FCPA violations - June 26, 2020
Novartis Q1 core profit rises - April 28, 2020
Novartis to acquire The Medicines Company for $9.7 billion - November 26, 2019
Novartis Q3 profit up - October 22, 2019
Bribed politicians: Court in Greece sends Novartis case file to parliament - September 14, 2019
Novartis to answer U.S. Senate demand for data manipulation details - August 19, 2019
Novartis CEO says they will not sell Sandoz generics unit - July 27, 2019
Novartis sells one cancer therapy treatment for $374,828.50 - July 5, 2019
Glenmark Pharmaceuticals to partner with Novartis in Brazil - June 24, 2019
GSK and Novartis allegedly misled consumers with Voltaren Osteo Gel claims - May 21, 2019
Novartis buys dry eye drug from Takeda for up to $5.3 billion - May 9, 2019
Novartis to buy anti-inflammatory group IFM Tre - April 1, 2019
Novartis Q3 net income down 22% - October 18, 2018
Novartis to buy cancer drugmaker Endocyte for $2.1 billion in cash - October 18, 2018
Novartis to cut 1,000 jobs - September 26, 2018
Novartis eyecare unit Alcon to move global headquarters to Geneva - September 12, 2018
Mylan closes deal with Novartis To commercialize certain global cystic fibrosis products - September 6, 2018
Novartis Q2 profit surges to $7.77 billion - July 18, 2018
Novartis seek shareholder approval for spinoff of Alcon eye care - June 29, 2018
Novartis Q1 net sales $12.7 billion - April 19, 2018
Novartis to buy AveXis for $8.7 billion - April 9, 2018
GSK to buy Novartis stake in JV for $13 billion - March 27, 2018
Novartis faces bribery probe in Greece - February 14, 2018
Novartis Q4 EPS up 113 percent - January 24, 2018
Australia takes GSK, Novartis to court over misleading claims - December 6, 2017
Novartis agrees to buy AAA in $3.9 billion deal - October 30, 2017
Novartis Q3 net income increased 7 percent - October 24, 2017
Novartis to charge $475,000 a patient for breakthrough cancer drug - August 31, 2017
Novartis Q2 profit up, net sales down - July 18, 2017
South Korea to halt benefits to Novartis, fines it $49.5 million - May 25, 2017
Novartis to cut around 500 jobs in Switzerland, add 350 - May 19, 2017
Novartis Q1 profit down on weak sales - April 25, 2017
Russian FAS opened a case against Novartis Pharma - April 22, 2017
Novartis investing EUR 105 million in new facility in Slovenia - April 19, 2017
Novartis announced $5 billion buyback - January 25, 2017
Novartis giving $1.6 billion to get access to two cardio drugs - January 6, 2017
Novartis buys Selexys Pharmaceuticals in $665 million deal - November 21, 2016
Novartis chairman thinking about sale of Alcon eye care division - November 14, 2016
Novartis Q3 net income increased 7 percent - October 25, 2016
Novartis Q2 profit down, FY core outlook down - July 19, 2016
Novartis still has a chance in Colombia - May 18, 2016
Novartis appoints leaders for two new business units - May 18, 2016
Novartis splits drugs business into two - May 18, 2016
Novartis Q1 net sales $11.6 billion, net income $2 billion - April 21, 2016
Sun Pharma to buy 14 Rx brands from Novartis in Japan for $293m - March 29, 2016
Novartis profit drops 57%, weak performance of eye-care unit - January 27, 2016
Novartis Q3 net sales $12.3 billion, EPS $0.75 - October 27, 2015
Novartis buys another 2.5% in Gamida Cell for $5 million - October 12, 2015
Novartis is buying ofatumumab from GSK for $1 billion - August 21, 2015
Novartis delivers solid performance in Q2 - July 21, 2015
Novartis to buy Spinifex Pharmaceuticals to focus on neuropathic pain - June 29, 2015
Novartis delivered sales growth and margin expansion in Q1 - April 23, 2015
Novartis sales of $14.6 billion decrease 2% - January 28, 2015
Novartis completes divestment of Animal Health business to Eli Lilly for $5.4 billion - January 5, 2015
Novartis appoints Jeff George as division head, Alcon - April 9, 2014
Qu Biologics appoints former Novartis president to the board - June 14, 2013
Novartis announces update to company's board of directors - November 15, 2012